Investments
3Portfolio Exits
2Funds
27Service Providers
1About DB Private Equity
DB Private Equity is amongst the leading alternative investment managers in Europe. DB Private Equity focuses on primary and secondary fund investments as well as direct co-investments for institutional investors and high net worth individuals worldwide. It offers its clients broad diversified or specialized fund-of-funds as well as customized separate managed accounts. In addition, DB Private Equity possesses comprehensive knowledge and expertise in venture capital investments.
DB Private Equity Headquarter Location
Elsa-Brändström-Str. 10-12
Cologne, D-50668,
Germany
Latest DB Private Equity News
Jul 30, 2018
DeltaMed (Augens Capital e DB) compra il controllo di Bioengineering Laboratories Delta Med spa, l’ex controllata della quotata Eukedos (ex Arkimedica), ha annunciato nei giorni scorsi l’accordo per l’acquisizione del 77% del capitale di Bioengineering Laboratories srl, al fianco del fondatore, Francesco Greco, che manterrà una quota del 23% nel capitale e verrà nominato amministratore delegato della società responsabile degli affari medici e scientifici di Delta Med (scarica qui il comunicato stampa ). Bioengineering Laboratories progetta, sviluppa, produce e distribuisce dispositivi medici certificati con particolare riferimento agli accessi vascolari per trattamenti di dialisi acuta, dispositivi medici monouso per urodinamica, cardiochirurgia e critical care e ha di recente ottenuto il prestigioso Sigillo di Eccellenza della Commissione Europea per il progetto Dyalibrid, concepito per innovare il mondo dell’emodialisi con un innovativo accesso vascolare ibrido basato sul materiale Silkothane. Delta Med è controllata dal novembre 2015 da Augens Capital srl (guidato da Marco Mantica), in partnership con il fondo SOF gestito da DB Private Equity (la divisione di private equity di Deutsche Bank) (si veda altro articolo di BeBeez ). Nell’operazione Delta Med è stata assistita dallo studio legale LMS e da EY per la due-diligence contabile e fiscale. La società è controllata da Augens Holding in partnership con il fondo SOF gestito da DB Private Equity e con il management della società. Fondata nel 1993, Delta Med è uno dei principali produttori mondiali di accessi vascolari periferici ed è inoltre attiva nella produzione e distribuzione in Italia e all’estero di dispositivi medici e accessori monouso per terapie infusionali, pacchi procedurali per sale operatorie e altri prodotti per il settore farmaceutico, ospedaliero e dentale. L’acquisizione del ramo d’azienda di Alfamed si inserisce nelle linee strategiche di sviluppo avviate da Augens Capital, che prevedono la creazione di un grande operatore italiano che disponga di un sofisticato e completo portafoglio di prodotti e tecnologie nell’area degli accessi vascolari. Primo passo di questa strategia è stato l’acquisizione del 100% di Tipromed srl nel gennaio 2017, mentre nel settembre 2017 è stata acquisita la divisione Critical Care di Alfamed (si veda altro articolo di BeBeez ). Con questa terza acquisizione, DeltaMed, sotto la guida dell’amministratore delegato Gabriele Giovanelli, raggiunge così un fatturato consolidato pro-forma di oltre 25 milioni di euro, di cui più del 50% realizzato nei mercati internazionali, con oltre 100 dipendenti.
DB Private Equity Investments
3 Investments
DB Private Equity has made 3 investments. Their latest investment was in Windeln.de as part of their Series D on May 5, 2014.
DB Private Equity Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
5/13/2014 | Series D | Windeln.de | $20.55M | Yes | 1 | |
6/9/2008 | Growth Equity - II | |||||
11/29/2006 | Growth Equity |
Date | 5/13/2014 | 6/9/2008 | 11/29/2006 |
---|---|---|---|
Round | Series D | Growth Equity - II | Growth Equity |
Company | Windeln.de | ||
Amount | $20.55M | ||
New? | Yes | ||
Co-Investors | |||
Sources | 1 |
DB Private Equity Portfolio Exits
2 Portfolio Exits
DB Private Equity has 2 portfolio exits. Their latest portfolio exit was Windeln.de on May 06, 2015.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
5/6/2015 | IPO | 1 | |||
Date | 5/6/2015 | |
---|---|---|
Exit | IPO | |
Companies | ||
Valuation | ||
Acquirer | ||
Sources | 1 |
DB Private Equity Acquisitions
1 Acquisition
DB Private Equity acquired 1 company. Their latest acquisition was Medi-Globe on March 02, 2016.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
3/2/2016 | Acq - Fin | 2 |
Date | 3/2/2016 |
---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acq - Fin |
Sources | 2 |
DB Private Equity Fund History
27 Fund Histories
DB Private Equity has 27 funds, including German Access Fund LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
11/1/2016 | German Access Fund LP | Diversified Private Equity | Closed | $275.33M | 1 |
10/21/2014 | Secondary Opportunities Fund III (SOF III) | LP Secondaries | Closed | $1,655M | 1 |
4/8/2013 | Global Select Fund VI | Fund Of Funds | Open | $53M | 1 |
12/31/2012 | DB SOF II | ||||
12/31/2011 | DB Impact Investment Fund |
Closing Date | 11/1/2016 | 10/21/2014 | 4/8/2013 | 12/31/2012 | 12/31/2011 |
---|---|---|---|---|---|
Fund | German Access Fund LP | Secondary Opportunities Fund III (SOF III) | Global Select Fund VI | DB SOF II | DB Impact Investment Fund |
Fund Type | Diversified Private Equity | LP Secondaries | Fund Of Funds | ||
Status | Closed | Closed | Open | ||
Amount | $275.33M | $1,655M | $53M | ||
Sources | 1 | 1 | 1 |
DB Private Equity Service Providers
1 Service Provider
DB Private Equity has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Counsel |
Service Provider | |
---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type |
Partnership data by VentureSource
DB Private Equity Team
12 Team Members
DB Private Equity has 12 team members, including current Managing Director, Andreas Schmidt.
Name | Work History | Title | Status |
---|---|---|---|
Andreas Schmidt | Managing Director | Current | |
Andreas Schmidt | Managing Director | Current | |
Jan von Bassewitz | Managing Director | Current | |
Karim Ghanam | Managing Director | Former | |
Chris Minter | Managing Director | Former |
Name | Andreas Schmidt | Andreas Schmidt | Jan von Bassewitz | Karim Ghanam | Chris Minter |
---|---|---|---|---|---|
Work History | |||||
Title | Managing Director | Managing Director | Managing Director | Managing Director | Managing Director |
Status | Current | Current | Current | Former | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.